EP3463458
COMBINED USE OF MARIZOMIB AND BEVACIZUMAB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
1.6.2017:
10.4.2024:
17730628.9
:
31.5.2037
:
COMBINED USE OF MARIZOMIB AND BEVACIZUMAB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS
1.6.2017
10.4.2024
:
Celgene Tri A Holdings Ltd.:
Aon House 30 Woodbourne Avenue, Pembroke HM 08, BM
:
Trikha, Mohit:
3366 N. Torrey Pines Court 210, La Jolla, California 92037, US
:
Levin, Nancy:
3366 N. Torrey Pines Court 210, La Jolla, California 92037, US
:
Maclaren, Ann:
3366 N. Torrey Pines Court 210, La Jolla, California 92037, US
:
TRIKHA, Mohit:
La Jolla California 92037, US
:
LEVIN, Nancy:
La Jolla California 92037, US
:
MACLAREN, Ann:
La Jolla California 92037, US
:
201662344194 P:
1.6.2016:
US
:
201662349491 P:
13.6.2016:
US
:
201662362845 P:
15.7.2016:
US
:
201662374136 P:
12.8.2016:
US
:
201662418466 P:
7.11.2016:
US
:
201662424178 P:
18.11.2016:
US
:
201762471321 P:
14.3.2017:
US
:
201762490528 P:
26.4.2017:
US
:
201762491943 P:
28.4.2017:
US
:
US2017035504:
1.6.2017
:
A61K 39/395, A61K 31/407, A61K 31/495, A61P 35/00, A61P 35/02